九强生物
(300406)
| 流通市值：48.37亿 | | | 总市值：66.82亿 |
| 流通股本：4.24亿 | | | 总股本：5.86亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 678,677,570.36 | 334,810,688.09 | 1,355,507,324.47 | 1,011,713,943.43 |
| 营业总成本 | 431,318,772.74 | 217,562,849.44 | 929,773,807.64 | 694,610,808.39 |
| 其他经营收益 | | | | |
| 营业利润 | 240,616,055.32 | 123,942,303.12 | 235,982,871.91 | 307,842,002.72 |
| 利润总额 | 240,544,110.53 | 123,984,338.47 | 236,252,138.82 | 306,960,707.65 |
| 净利润 | 210,336,063.58 | 105,611,273 | 190,537,287.77 | 273,070,841.15 |
| 每股收益 | | | | |
| 其他综合收益 | -643,149.69 | -338,607.92 | -495,498.1 | -233,627.67 |
| 综合收益总额 | 209,692,913.89 | 105,272,665.08 | 190,041,789.67 | 272,837,213.48 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,109,012,176.83 | 2,348,546,132.61 | 2,199,691,700.26 | 2,429,825,802.08 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,762,962,072.05 | 2,834,715,101.53 | 2,852,739,493.23 | 2,865,220,909.02 |
| 资产总计 | 4,871,974,248.88 | 5,183,261,234.14 | 5,052,431,193.49 | 5,295,046,711.1 |
| 流动负债: | | | | |
| 流动负债合计 | 177,964,949.96 | 192,869,548.95 | 171,316,477.4 | 208,320,430.35 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,111,913,538.1 | 1,104,898,705.78 | 1,098,254,997.76 | 1,091,493,781.23 |
| 负债合计 | 1,289,878,488.06 | 1,297,768,254.73 | 1,269,571,475.16 | 1,299,814,211.58 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,588,043,413.03 | 3,891,389,331.11 | 3,788,015,483.72 | 4,000,375,714.95 |
| 股东权益合计 | 3,582,095,760.82 | 3,885,492,979.41 | 3,782,859,718.33 | 3,995,232,499.52 |
| 负债和股东权益合计 | 4,871,974,248.88 | 5,183,261,234.14 | 5,052,431,193.49 | 5,295,046,711.1 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 747,981,876.27 | 342,020,999.72 | 1,615,329,769.15 | 1,209,072,997.52 |
| 经营活动现金流出小计 | 501,186,059.77 | 246,514,762.96 | 1,050,220,018.18 | 782,239,426.33 |
| 经营活动产生的现金流量净额 | 246,795,816.5 | 95,506,236.76 | 565,109,750.97 | 426,833,571.19 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 237,920,656.61 | 50,330,700 | 73,632,641.27 | 43,724,876.27 |
| 投资活动现金流出小计 | 90,474,690.78 | 9,107,025.68 | 548,952,695.86 | 293,312,420.48 |
| 投资活动产生的现金流量净额 | 147,445,965.83 | 41,223,674.32 | -475,320,054.59 | -249,587,544.21 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,201,179.06 | 355,177.09 | 7,489,413.95 | 6,168,419.44 |
| 筹资活动现金流出小计 | 429,409,837.49 | 3,190,683.94 | 688,302,660.31 | 570,488,806.53 |
| 筹资活动产生的现金流量净额 | -428,208,658.43 | -2,835,506.85 | -680,813,246.36 | -564,320,387.09 |
| 汇率变动对现金及现金等价物的影响 | -412,679.54 | -194,057.48 | -389,715.5 | -164,996.95 |
| 现金及现金等价物净增加额 | -34,379,555.64 | 133,700,346.75 | -591,413,265.48 | -387,239,357.06 |
| 期末现金及现金等价物余额 | 505,265,580.72 | 673,345,483.11 | 539,645,136.36 | 743,819,044.78 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -34,379,555.64 | - | -591,413,265.48 | - |
最新报告期：2026-08-25| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 光大证券 | 黎一江 | 0.68 | 0.87 | 1.04 | 2026-08-25 |
| 中泰证券 | 祝嘉琦,谢木青 | 0.71 | 0.82 | 0.91 | 2026-08-24 |